CD160 and Schwartz-Jampel syndrome: Here, we sought to examine the BTLA/HVEM/CD160/LIGHT co-signaling network in SjS to elucidate the role of this pathway in disease pathogenesis, to identify peripheral blood biomarkers of disease, and to investigate the potential of targeting this network therapeutically.